In a positive development for US drug giant Pfizer, the country’s Intellectual Property Appellate Board (IPAB) has issued an interim stay on an order stated by the Indian Patent Office removing a patent of Pfizer, for its extended release drug Tolterodine (Detrol), which is used for treating old age patients who suffer from frequent urination. 901 more words
Tags » Patents
The US Patent and Trademark Office (USPTO) has announced that it is extending a popular program that allows patent applicants to submit minor amendments to their patent applications even after final rejection. 403 more words
The US Supreme Court has agreed to hear a case involving the standards for determining whether a patent is invalid as indefinite.
Nautilus Inc. v. Biosig Instruments Inc. 342 more words